Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-02-20
DOI
10.3389/fphys.2018.00114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of NLRP1-Mediated Autoinflammatory Disease in Humans and Mice
- (2018) Chien-Hsiung Yu et al. JOURNAL OF MOLECULAR BIOLOGY
- Interleukin-18: Biological properties and role in disease pathogenesis
- (2017) Gilles Kaplanski IMMUNOLOGICAL REVIEWS
- MLKL Activation Triggers NLRP3-Mediated Processing and Release of IL-1β Independently of Gasdermin-D
- (2017) Kimberley D. Gutierrez et al. JOURNAL OF IMMUNOLOGY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition
- (2017) Paul J. Baker et al. PHYSIOLOGICAL REVIEWS
- Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus
- (2017) Yao Wang et al. PLoS One
- Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner
- (2017) Stephanie A. Conos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
- (2017) Shaofei Wang et al. Cell Death & Disease
- LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy
- (2017) Hong Yi et al. Cell Death & Disease
- Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling
- (2017) Miaomiao Lu et al. Biomed Research International
- Function of NLRP3 in the Pathogenesis and Development of Diabetic Nephropathy
- (2017) Ying Fu et al. MEDICAL SCIENCE MONITOR
- NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
- (2017) Beibei Luo et al. Frontiers in Physiology
- Cell death is not essential for caspase-1-mediated interleukin-1β activation and secretion
- (2016) S A Conos et al. CELL DEATH AND DIFFERENTIATION
- IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic Syndrome
- (2016) Andrew J. Murphy et al. Cell Metabolism
- The intersection of cell death and inflammasome activation
- (2016) James E. Vince et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
- (2016) Manasi S. Shah et al. CIRCULATION RESEARCH
- Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice
- (2016) E. Di Marco et al. CLINICAL SCIENCE
- GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
- (2016) Lorenzo Sborgi et al. EMBO JOURNAL
- Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)
- (2016) Neil A. Turner JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
- (2016) K. Shahzad et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/−Mice
- (2016) Weiling Leng et al. MEDIATORS OF INFLAMMATION
- Pore-forming activity and structural autoinhibition of the gasdermin family
- (2016) Jingjin Ding et al. NATURE
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes
- (2016) Robin A. Aglietti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice
- (2016) Gustavo Monnerat et al. Nature Communications
- Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
- (2016) Eri H. Kobayashi et al. Nature Communications
- β-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation
- (2016) Ha Ram Bae et al. Oncotarget
- NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
- (2016) Geena Paramel Varghese et al. Journal of the American Heart Association
- High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells
- (2016) Hong Feng et al. Journal of Diabetes Research
- Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy
- (2016) Khurrum Shahzad et al. Scientific Reports
- Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
- (2015) Mitchel Tate et al. BASIC RESEARCH IN CARDIOLOGY
- Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet
- (2015) A. Abderrazak et al. CIRCULATION
- Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a pos
- (2015) P. Ruscitti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The role of NADPH Oxidase in Vascular Disease – Hypertension, Atherosclerosis & Stroke
- (2015) Stephen Gray et al. CURRENT PHARMACEUTICAL DESIGN
- Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats
- (2015) Irene Paterniti et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development inLdlr−/−mice
- (2015) Tim Hendrikx et al. FEBS Journal
- A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation
- (2015) Jonathan L. Schmid-Burgk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Importance of NLRP3 Inflammasome in Heart Failure
- (2015) Brittany Butts et al. JOURNAL OF CARDIAC FAILURE
- Interleukin-18-induced atherosclerosis involves CD36 and NF-κB crosstalk in Apo E−/− mice
- (2015) Owais Mohammad Bhat et al. Journal of Cardiology
- Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism
- (2015) Allison J. Greaney et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells
- (2015) Norihiko Sakai et al. KIDNEY INTERNATIONAL
- Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
- (2015) Khurrum Shahzad et al. KIDNEY INTERNATIONAL
- Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
- (2015) Nobuhiko Kayagaki et al. NATURE
- Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
- (2015) Jianjin Shi et al. NATURE
- NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component
- (2015) Hexin Shi et al. NATURE IMMUNOLOGY
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
- (2015) Guanghong Jia et al. Nature Reviews Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- NLRP3Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
- (2015) Jasna Klen et al. Journal of Diabetes Research
- Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
- (2015) Xin Shi et al. Journal of Stroke & Cerebrovascular Diseases
- Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes
- (2014) Luca De Nicola et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice
- (2014) Jian Cai et al. Cardiovascular Diabetology
- The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
- (2014) Susana Vallejo et al. Cardiovascular Diabetology
- Prion-like Polymerization Underlies Signal Transduction in Antiviral Immune Defense and Inflammasome Activation
- (2014) Xin Cai et al. CELL
- Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
- (2014) Alvin Lu et al. CELL
- Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
- (2014) Nathalie Esser et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Nuclear Factor E2-related Factor-2 (Nrf2) Is Required for NLRP3 and AIM2 Inflammasome Activation
- (2014) Changcheng Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondrial NLRP3 Protein Induces Reactive Oxygen Species to Promote Smad Protein Signaling and Fibrosis Independent from the Inflammasome
- (2014) Nathan A. Bracey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
- (2014) Scott W Canna et al. NATURE GENETICS
- The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
- (2014) Bernardo S Franklin et al. NATURE IMMUNOLOGY
- Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
- (2014) Ivana Vrhovac et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
- (2014) Beibei Luo et al. PLoS One
- The Neutrophil NLRC4 Inflammasome Selectively Promotes IL-1β Maturation without Pyroptosis during Acute Salmonella Challenge
- (2014) Kaiwen W. Chen et al. Cell Reports
- Ambiguities in NLRP3 inflammasome regulation: Is there a role for mitochondria?
- (2013) Kate E. Lawlor et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The NLRP3 Inflammasome and Diabetic Cardiomyopathy
- (2013) Lalit P. Singh CARDIOVASCULAR DRUGS AND THERAPY
- Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
- (2013) Beibei Luo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility
- (2013) Han Xiao et al. CIRCULATION
- Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice
- (2013) Atsuo Tahara et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
- (2013) Stacey Ruiz et al. KIDNEY INTERNATIONAL
- CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
- (2013) Frederick J Sheedy et al. NATURE IMMUNOLOGY
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
- (2013) Usha Panchapakesan et al. PLoS One
- Activation of Sterol Regulatory Element Binding Protein and NLRP3 Inflammasome in Atherosclerotic Lesion Development in Diabetic Pigs
- (2013) Yu Li et al. PLoS One
- Oxidized Low Density Lipoprotein Induced Caspase-1 Mediated Pyroptotic Cell Death in Macrophages: Implication in Lesion Instability?
- (2013) Jing Lin et al. PLoS One
- Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
- (2013) Marina Bayeva et al. Journal of the American Heart Association
- Caspase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E-Null Mice
- (2012) Jessica Gage et al. CANADIAN JOURNAL OF CARDIOLOGY
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
- (2012) M. Rajesh et al. DIABETES
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Increased Inflammation in Atherosclerotic Lesions of DiabeticAkita-LDLr−/−Mice Compared to NondiabeticLDLr−/−Mice
- (2012) Daniel Engelbertsen et al. Experimental Diabetes Research
- The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats
- (2012) W.B. Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
- (2011) P. Menu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis
- (2011) Gavin C. K. W. Koh et al. CLINICAL INFECTIOUS DISEASES
- Understanding the mechanism of IL-1β secretion
- (2011) Gloria Lopez-Castejon et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
- (2011) Yun-Hee Youm et al. ENDOCRINOLOGY
- Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis
- (2011) Stefan Freigang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-1 and atherosclerosis: a murine twist to an evolving human story
- (2011) Daniel J. Rader JOURNAL OF CLINICAL INVESTIGATION
- Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
- (2011) Haitao Wen et al. NATURE IMMUNOLOGY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Inflammasome is a central player in the induction of obesity and insulin resistance
- (2011) R. Stienstra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
- (2011) P Menu et al. Cell Death & Disease
- NF-E2–Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection
- (2010) Berenice Barajas et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
- (2010) Rinke Stienstra et al. Cell Metabolism
- Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy
- (2010) Himanshu Sharma et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
- Myocardial remodeling after infarction: the role of myofibroblasts
- (2009) Susanne W. M. van den Borne et al. Nature Reviews Cardiology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search